UBA1 and VEXAS syndrome: Taken together, these data place the UBA1-ER-stress–inflammasome axis at the core of VEXAS pathogenesis and provide a rationale for therapeutic strategies that directly inhibit NLRP3, caspase-1, or downstream IL-1 signalling.